|
[1]DESMET VJ, ROSKAMS T.Cirrhosis reversal:a duel between dogma and myth[J].J Hepatol, 2004, 40 (5) :860-867.
|
|
[2]LEFTON HB, ROSA A, COHEN M.Diagnosis and epidemiology of cirrhosis[J].Med Clin North Am, 2009, 93 (4) :787-799.
|
|
[3]BEDOSSA P, POYNARD T.An algorithm for the grading of activity inchronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.
|
|
[4]ROMERO-GMEZ M, GMEZ-GONZLEZ E, MADRAZO A, et al.Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C[J].Hepatology, 2008, 47 (3) :810-816.
|
|
[5]TAURA T, NAKAMURA K, TAKASHIMA S, et al.Heterogeneity of hepatic parenchymal enhancement on computed tomography during arterial portography:quantitative analysis of correlation with severity of hepatic fibrosis[J].Hepatol Res, 2001, 20 (2) :182-192.
|
|
[6]NAKAURA T, NAKAMURA S, MARUYAMA N, et al.Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT:effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality[J].Radiology, 2012, 264 (2) :445-454.
|
|
[7]COULON S, HEINDRYCKX F, GEERTS A, et al.Angiogenesis in chronic liver disease and its complications[J].Liver Int, 2011, 31 (2) :146-162.
|
|
[8]ZHONG L, WANG WJ, XU JR, et al.Clinical application of hepatic CT perfusion[J].World J Gastroenterol, 2009, 15 (18) :907-911.
|
|
[9]RONOT M, ASSELAH T, PARADIS V, et al.Liver fibrosis in chronic hepatitis C virus infection:differentiating minimal from intermediate fibrosis with perfusion CT[J].Radiology, 2010, 256 (1) :135-142.
|
|
[10]VILLENEUVE JP, DAGENAIS M, HUET PM, et al.The hepatic microcirculation in the isolated perfused human liver[J].Hepatology, 1996, 23 (1) :24-31.
|
|
[11]SAHIN S, ROWLAND M.Estimation of aqueous distributional spaces in the dual perfused rat liver[J].J Physiol, 2000, 528 (Pt1) :199-207.
|
|
[12]VARENIKA V, FU Y, MAHER JJ, et al.Hepatic fibrosis:evaluation with semiquantitative contrast-enhanced CT[J].Radiology, 2013, 266 (1) :151-158.
|
|
[13]YAN FH.Paying attention to quantitative study and clinical application of new techniques of abdominal CT and MR[J].Chin J Radiol, 2013, 47 (2) :101-103. (in Chinese) 严福华.重视腹部CT和MR新技术的量化研究和临床应用[J].中华放射学杂志, 2013, 47 (2) :101-103.
|
|
[14]LYU P, LIN X, GAO J, et al.Spectral CT:preliminary studies in the liver cirrhosis[J].Korean J Radiol, 2012, 13 (4) :434-442.
|
|
[15]MACARINI L, MARINI S, MILILLO P, et al.Double-contrast MRI (DCMRI) in the study of the cirrhotic liver:utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptakeand distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions[J].Radiol Med, 2006, 111 (8) :1087-1102.
|
|
[16]AGUIRRE DA, BEHLING CA, ALPERT E, et al.Liver fibrosis:noninvasive diagnosis with double contrast material-enhanced MR imaging[J].Radiology, 2006, 239 (2) :425-437.
|
|
[17]NISHIE A, ASAYAMA Y, ISHIGAMI K, et al.MR prediction of liver fibrosis using a liver-specific contrast agent:Superparamagnetic iron oxide versus Gd-EOB-DTPA[J].J Magn Reson Imaging, 2012, 36 (3) :664-671.
|
|
[18]NORéN B, FORSGREN MF, DAHLQVIST LEINHARD O, et al.Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA[J].Eur Radiol, 2013, 23 (1) :174-181.
|
|
[19]MOTOSUGI U, ICHIKAWA T, SANO K, et al.Magnetic resonance elastography of the liver:preliminary results and estimation of inter-rater reliability[J].Jpn J Radiol, 2010, 28 (8) :623-627.
|
|
[20]SHIRE NJ, YIN M, CHEN J, et al.Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C[J].J Magn Reson Imaging, 2011, 34 (4) :947-955.
|
|
[21]YOON JH, LEE JM, WOO HS, et al.Staging of hepatic fibrosis:comparison of magnetic resonance elastography and shear wave elastography in the same individuals[J].Korean J Radiol, 2013, 14 (2) :202-212.
|
|
[22]WANG QB, ZHU H, LIU HL, et al.Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:a meta-analysis[J].Hepatology, 2012, 56 (1) :239-247.
|
|
[23]LUCIANI A, VIGNAUD A, CAVET M, et al.Liver cirrhosis:intravoxel incoherent motion MR imaging-pilot study[J].Radiology, 2008, 249 (3) :891-899.
|
|
[24]DYVORNE HA, GALEA N, NEVERS T.Diffusion-weighted imaging of the liver with multiple b values:effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study[J].Radiology, 2013, 266 (3) :920-929.
|
|
[25]HAGIWARA M, RUSINEK H, LEE VS, et al.Advanced liver fibrosis:diagnosis with 3D whole-liver perfusion MR imaging-initial experience1[J].Radiology, 2008, 246 (3) :926-934.
|
|
[26]NOREN B, DAHLQVIST O, LUNDBERG P, et al.Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy[J].Eur J Radiol, 2008, 66 (2) :313-320.
|
|
[27]WONG VW, CHU WC, WONG GL, et al.Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese:a population study using proton-magnetic resonance spectroscopy and transient elastography[J].Gut, 2012, 61 (3) :409-415.
|
|
[28]POLASEK M, FUCHS BC, UPPAL R, et al.Molecular MR imaging of liver fibrosis:a feasibility study using rat and mouse models[J].J Hepatol, 2012, 57 (3) :549-555.
|
|
[29]CHOW AM, TAN M, GAO DS, et al.Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model[J].Invest Radiol, 2013, 48 (1) :46-54.
|
|
[30]BALASSY C, FEIER D, PECK-RADOSAVLJEVIC M, et al.Susceptibility-weighted MR imaging in the grading of liver fibrosis:a feasibility study[J].Radiology, 2013.[Epub ahead of print]
|
DownLoad: